Details van artikel 469 van 503 gevonden artikelen
SO-1 A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH1 and IDH2, as monotherapy and in combination with cisplatin and gemcitabine in advanced IDH-mutant cholangiocarcinoma
Titel:
SO-1 A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH1 and IDH2, as monotherapy and in combination with cisplatin and gemcitabine in advanced IDH-mutant cholangiocarcinoma
Auteur:
Harding, J. Ikeda, M. Goyal, L. Rodon, J. Bai, L. Oh, D. Park, J. Chen, L. Ueno, M. Liao, C. Kondo, S. Cosman, R. Yokota, T. Shroff, R. Satoh, T. Palmieri, L. Hollebecque, A. Adeva, J. Bender, M. Liu, H. Macarulla, T.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 34 () nr. S1 pagina's S161
Jaar:
2023
Inhoud:
Uitgever:
Published by Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 469 van 503 gevonden artikelen